Trial intelligence / Profile preview

Acetazolamide add-on to OSA surgery

NCT04227093Phase 4Active, not recruiting

Start
Jan 2020
Primary completion
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetazolamide in obstructive sleep apnea (OSA). Started Jan 2020; status: active, not recruiting.

02

Drugs

acetazolamide
03

Conditions

obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT04227093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04227093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call